Table 1. Patient Characteristics.
| Group P (n = 31) | Group S (n = 19) | P value | |
|---|---|---|---|
| Age (yr) | 61.2 ± 11.8 | 62.7 ± 8.3 | 0.632 |
| Sex (M/F) | 16/15 | 10/9 | 0.944 |
| BMI (kg/m2) | 23.7 ± 3.0 | 23.7 ± 3.7 | 0.610 |
| ASA (1 and 2/3) | 15/16 | 9/10 | 0.944 |
| Operation time (min) | 238.2 ± 38.1 | 243.7 ± 37.3 | 0.623 |
| Anesthetic time (min) | 310.6 ± 42.9 | 315.8 ± 40.5 | 0.676 |
| Hypoxia OP | 15 (48.4) | 9 (47.4) | 0.944 |
| Past Medical History | 18 (58.1) | 9 (47.4) | 0.461 |
| Hypertension | 11 (35.5) | 5 (26.3) | 0.500 |
| DM | 12 (38.7) | 2 (10.5) | 0.031 |
| Previous lung OP | 1 (3.2) | 1 (5.3) | 1.000 |
| CVA | 4 (12.9) | 0 (0.0) | 0.284 |
| IHD | 3 (9.7) | 1 (5.3) | 1.000 |
| COPD | 0 (0) | 2 (10.5) | 0.140 |
| Atrial fibrillation | 0 (0) | 2 (10.5) | 0.140 |
Data are presented as mean ± SD or number of patients (%). Group P: Pyridostigmine administration, Group S: Sugammadex administration. BMI: body mass index, ASA: American Society of Anesthesiologists physical status classification, OP: operation, DM: diabetes mellitus, CVA: cerebrovascular accident, IHD: ischemic heart disease, COPD: chronic obstructive pulmonary disease.